Elevance Health, Inc. financial data

Symbol
ELV on NYSE
Location
220 Virginia Avenue, Indianapolis, IN
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Oct 21, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 147 % +1.62%
Debt-to-equity 180 % +5.33%
Return On Equity 12.9 % -16.6%
Return On Assets 4.6 % -19.3%
Operating Margin 3.88 % -20.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 222M shares -4.18%
Common Stock, Shares, Outstanding 222M shares -4.27%
Entity Public Float 117B USD +11.5%
Common Stock, Value, Issued 2M USD 0%
Weighted Average Number of Shares Outstanding, Basic 223M shares -3.71%
Weighted Average Number of Shares Outstanding, Diluted 224M shares -4.03%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 195B USD +11.8%
Operating Income (Loss) 7.56B USD -10.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 7.1B USD -14.4%
Income Tax Expense (Benefit) 1.57B USD -17.6%
Net Income (Loss) Attributable to Parent 5.53B USD -13.8%
Earnings Per Share, Basic 24 USD/shares -11.1%
Earnings Per Share, Diluted 24 USD/shares -10.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 8.71B USD +10.8%
Other Assets, Current 5.21B USD -12.4%
Assets, Current 63.8B USD +1.48%
Other Long-term Investments 10.6B USD +13.3%
Property, Plant and Equipment, Net 4.66B USD +3.37%
Operating Lease, Right-of-Use Asset 567M USD -2.91%
Intangible Assets, Net (Excluding Goodwill) 11.3B USD +9.71%
Goodwill 28.5B USD +9.57%
Other Assets, Noncurrent 2.78B USD +6.69%
Assets 123B USD +5.33%
Liabilities, Current 40.9B USD -2.75%
Deferred Income Tax Liabilities, Net 2.32B USD +10.7%
Operating Lease, Liability, Noncurrent 658M USD -3.94%
Other Liabilities, Noncurrent 4.14B USD +15.1%
Liabilities 78.7B USD +8.28%
Accumulated Other Comprehensive Income (Loss), Net of Tax -543M USD -11%
Retained Earnings (Accumulated Deficit) 35.6B USD +1.22%
Stockholders' Equity Attributable to Parent 44B USD +0.41%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 44.1B USD +0.46%
Liabilities and Equity 123B USD +5.33%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 1.02B USD -48.6%
Net Cash Provided by (Used in) Financing Activities -1.91B USD -6066%
Net Cash Provided by (Used in) Investing Activities 103M USD
Common Stock, Shares Authorized 900M shares 0%
Common Stock, Shares, Issued 222M shares -4.27%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -788M USD -163%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 8.71B USD +10.8%
Deferred Tax Assets, Valuation Allowance 294M USD +8.49%
Deferred Tax Assets, Gross 2.41B USD +11.8%
Operating Lease, Liability 811M USD -4.48%
Payments to Acquire Property, Plant, and Equipment 196M USD -29.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 5.48B USD -35.1%
Lessee, Operating Lease, Liability, to be Paid 886M USD -7.32%
Property, Plant and Equipment, Gross 8.33B USD +5.39%
Operating Lease, Liability, Current 153M USD -6.71%
Lessee, Operating Lease, Liability, to be Paid, Year Two 154M USD -7.78%
Lessee, Operating Lease, Liability, to be Paid, Year One 184M USD -5.64%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Deferred Income Tax Expense (Benefit) -174M USD -228%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 75M USD -29.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 127M USD -4.51%
Deferred Tax Assets, Operating Loss Carryforwards 428M USD +16.3%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 100M shares 0%
Unrecognized Tax Benefits 775M USD +65.6%
Lessee, Operating Lease, Liability, to be Paid, Year Four 112M USD +6.67%
Operating Lease, Payments 206M USD +0.98%
Additional Paid in Capital 8.91B USD -2.16%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 644M USD +4.38%
Depreciation, Depletion and Amortization 231M USD +5%
Deferred Tax Assets, Net of Valuation Allowance 2.12B USD +12.2%
Interest Expense 1.1B USD +10.4%